Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.
2.

The impact of implementation of neuromuscular blockade monitoring standards in a surgical intensive care unit.

Frankel H, Jeng J, Tilly E, St Andre A, Champion H.

Am Surg. 1996 Jun;62(6):503-6.

PMID:
8651538
3.

Prolonged neuromuscular blockade following vecuronium infusion.

Lagasse RS, Katz RI, Petersen M, Jacobson MJ, Poppers PJ.

J Clin Anesth. 1990 Jul-Aug;2(4):269-71.

PMID:
1975190
4.

Prolonged paralysis due to nondepolarizing neuromuscular blocking agents and corticosteroids.

Barohn RJ, Jackson CE, Rogers SJ, Ridings LW, McVey AL.

Muscle Nerve. 1994 Jun;17(6):647-54.

PMID:
7910951
5.

Prolonged neuromuscular blockade after long-term infusion of vecuronium bromide in the intensive care unit.

Partridge BL, Abrams JH, Bazemore C, Rubin R.

Crit Care Med. 1990 Oct;18(10):1177-9. No abstract available.

PMID:
1976485
6.

Persistent paralysis in critically ill patients after long-term administration of vecuronium.

Segredo V, Caldwell JE, Matthay MA, Sharma ML, Gruenke LD, Miller RD.

N Engl J Med. 1992 Aug 20;327(8):524-8.

7.

A retrospective analysis of long-term use of nondepolarizing neuromuscular blocking agents in the intensive care unit, and guidelines for drug selection.

Clarens DM, Kelly KJ, Gilliland SS, Kohls PK, Nahum A, Vance-Bryan K.

Pharmacotherapy. 1993 Nov-Dec;13(6):647-55.

PMID:
7905621
8.

Prolonged neuromuscular blockade in two critically ill patients treated with atracurium.

Hoey LL, Joslin SM, Nahum A, Vance-Bryan K.

Pharmacotherapy. 1995 Mar-Apr;15(2):254-9.

PMID:
7624274
9.
10.

[Muscle relaxants in the ICU].

Schneider G.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2009 May;44(5):358-64; quiz 366, 379. doi: 10.1055/s-0029-1224783. Epub 2009 May 13. German.

PMID:
19440945
11.
12.

Newer neuromuscular blocking agents: how do they compare with established agents?

Sparr HJ, Beaufort TM, Fuchs-Buder T.

Drugs. 2001;61(7):919-42. Review.

PMID:
11434449
13.

Continuous-infusion neuromuscular blocking agents in critically ill neonates and children.

Johnson PN, Miller J, Gormley AK.

Pharmacotherapy. 2011 Jun;31(6):609-20. doi: 10.1592/phco.31.6.609. Review.

PMID:
21923445
14.

A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients.

Rudis MI, Sikora CA, Angus E, Peterson E, Popovich J Jr, Hyzy R, Zarowitz BJ.

Crit Care Med. 1997 Apr;25(4):575-83.

PMID:
9142020
15.

The use of neuromuscular blocking drugs in intensive care practice.

Elliot JM, Bion JF.

Acta Anaesthesiol Scand Suppl. 1995;106:70-82. Review.

PMID:
8533552
16.

Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients.

Prielipp RC, Coursin DB, Scuderi PE, Bowton DL, Ford SR, Cardenas VJ Jr, Vender J, Howard D, Casale EJ, Murray MJ.

Anesth Analg. 1995 Jul;81(1):3-12.

PMID:
7598277
17.

Randomised controlled trial comparing cisatracurium and vecuronium infusions in a paediatric intensive care unit.

Burmester M, Mok Q.

Intensive Care Med. 2005 May;31(5):686-92. Epub 2005 Apr 7.

PMID:
15815895
18.

Neuromuscular blockade in cardiac surgery: an update for clinicians.

Hemmerling TM, Russo G, Bracco D.

Ann Card Anaesth. 2008 Jul-Dec;11(2):80-90. Review.

19.

Nondepolarizing neuromuscular blocking drugs in the intensive care unit: a clinical review.

Reeves ST, Turcasso NM.

South Med J. 1997 Aug;90(8):769-74. Review.

PMID:
9258301
20.

Prolonged paralysis after neuromuscular blockade.

Gooch JL.

J Toxicol Clin Toxicol. 1995;33(5):419-26. Review.

PMID:
7650766

Supplemental Content

Support Center